Search
dalteparin (Fragmin)
Tradename: Fragmin. (see low molecular weight heparin) safe in elderly (see low PREVENT trial)
Dosage:
1) 200 U/kg daily (full anticoagulation)
2) 2500 IU SC QD (DVT prophylaxis)
Adverse effects:
- see LMW heparin
Notes:
Equivalent to tinzaparin for treatment of:
1) deep vein thrombosis (DVT)
2) pulmonary embolism (PE)
Interactions
drug adverse effects of LMW heparin
Related
PREVENT trial
General
low molecular weight (LMW) heparin
References
- Drug Information & Medication Formulary, Veterans Affairs,
Central California Health Care System, 1st ed., Ravnan et al
eds, 1998
- Kaiser Permanente Northern California Regional Drug
Formulary, 1998
- Medical Knowledge Self Assessment Program (MKSAP) 11, 16.
American College of Physicians, Philadelphia 1998, 2012
- Journal Watch 25(10):78, 2005
Wells PS, Anderson DR, Rodger MA, Forgie MA, Florack P,
Touchie D, Morrow B, Gray L, O'Rourke K, Wells G, Kovacs J,
Kovacs MJ.
A randomized trial comparing 2 low-molecular-weight heparins
for the outpatient treatment of deep vein thrombosis and
pulmonary embolism.
Arch Intern Med. 2005 Apr 11;165(7):733-8.
PMID: 15824291